Vir Biotechnology, Inc.

NASDAQ:VIR

Biotechnology

Healthcare
$9.15 -2.63%

-$0.25 today

Market cap
$1.57B
Beta
1.64
P/E (TTM)
-3.0
EPS (TTM)
-$3.00
52W Low $4.16High $11.66

Volume 2.15M

Average 1.76M

Income Statement

Follow revenue through to earnings.

Revenue

$68.56M

FY 2025 · Annual

-7.6% YoY

Operating Income

-$468.02M

FY 2025 · Annual

Net Income

-$437.99M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.1B1.62B86.18M74.21M68.56M
Cost of Revenue513.87M620.97M572.83M478.65M11.71M
Gross Profit581.54M994.83M(486.65M)(404.44M)56.85M
Gross Margin53.1%61.6%-564.7%-545.0%82.9%
Research & Development448.01M474.65M579.72M506.5M432.8M
Selling, General & Admin000092.07M
Operating Expenses160.79M161.76M197.66M182.73M524.87M
Depreciation & Amortization5.81M6.78M19.45M14.56M11.68M
EBITDA555.61M761.06M(641.64M)(508.91M)(426.09M)
EBITDA Margin50.7%47.1%-744.5%-685.8%-621.5%
Operating Income420.75M833.07M(684.31M)(587.17M)(468.02M)
Operating Margin38.4%51.6%-794.0%-791.3%-682.7%
Interest Income439K28.09M86.99M71.81M40.24M
Interest Expense00000
Other Income / Expenses129.05M(78.79M)56.11M64.06M30.25M
Income Before Tax549.8M754.28M(628.19M)(523.11M)(437.77M)
Pre-Tax Margin50.2%46.7%-728.9%-704.9%-638.6%
Income Tax Expense21.22M238.44M(13.08M)(1.15M)217K
Net Income528.58M515.84M(615.06M)(521.96M)(437.99M)
Net Margin48.3%31.9%-713.7%-703.4%-638.9%
EPS (Basic)4.073.89(4.59)(3.83)(3.16)
EPS (Diluted)3.963.83(4.59)(3.83)(3.16)
Weighted Avg Shares129.88M132.61M134.13M136.25M138.52M
Weighted Avg Shares (Diluted)133.44M134.81M134.13M136.25M138.52M

VIR Earnings Waterfall · TTM

NASDAQ:VIR · Revenue to Net Income

Key Ratios

EPS$-3.13
Gross Margin-15118.2%
Net Margin89062.2%
P/E Ratio-2.6
P/S Ratio-10408.7

Analysis

$65.5M of revenue converted into -$442.7M of net income for the selected period. Gross margin is -15118.2% and net margin is 89062.2%, showing how much revenue survives after costs and taxes. EPS is $-3.13, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B5424B5 filingNov 12, 2026
S-3ASRS-3ASR filingNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 9, 2026
SC 13D/ASC 13D/A filingNov 6, 2026

How much revenue does VIR generate?

Vir Biotechnology, Inc. (VIR) reported $68.56M of revenue in fiscal 2025.

Is VIR profitable?

Vir Biotechnology, Inc. (VIR) reported -$437.99M of net income, with a net margin of -638.9%.